Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the safety and tolerability and to determine the
Pharmacokinetic and Pharmacodynamic (PK/PD) of ascending single oral dose of BR-A-657 in
healthy male subjects.